BCO vs GILD · P/E 25, rev $5.01B vs P/E 18, rev $29.44B
Brinks Company (BCO) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BCO and GILD stock pages for the full models.
Not investment advice.